Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (531-540 of 999) with videos related to

Pageof 100
Sort By:
American Journal of Epidemiology|July 3, 2013
The association of plasma lactate with incident cardiovascular outcomes: the ARIC StudyKunihiro Matsushita, Emma K Williams, Morgana L Mongraw-Chaffin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2016
Defective Association of the Platelet Glycoprotein Ib-IX Complex with the Glycosphingolipid-Enriched Membrane Domain Inhibits Murine Thrombus and Atheroma FormationHao Zhou, Yali Ran, Qi Da, et al.
Plos One|February 28, 2019
Central and peripheral pulse wave velocity and subclinical myocardial stress and damage in older adultsShuiqing Liu, Esther D Kim, Aozhou Wu, et al.
The American Journal of Cardiology|September 1, 2021
Association of Longitudinal Changes in Cardiac Biomarkers With Atrial and Ventricular Arrhythmias (from the Atherosclerosis Risk in Communities [ARIC] Study)Parveen K Garg, Faye L Norby, Wendy Wang, et al.
Journal of the American College of Cardiology|September 1, 2025
Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients: A Pooled AnalysisStephen J Nicholls, Adam J Nelson, Kausik K Ray, et al.
The American Journal of Cardiology|December 14, 2016
Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients with Hypercholesterolemia or Low High-Density Lipoprotein CholesterolChristie M Ballantyne, Sukrut Shah, Uma Kher, et al.
American Journal of Preventive Cardiology|March 10, 2025
Inflammatory markers and calcification of coronary arteries, aorta and cardiac valves: Findings from the atherosclerosis risk in communities studyVennela Avula, Yejin Mok, Kentaro Ejiri, et al.
Stroke|May 11, 2013
Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities studyRazvan T Dadu, Myriam Fornage, Salim S Virani, et al.
Atherosclerosis|January 28, 2019
Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities studyAnum Saeed, Wensheng Sun, Anandita Agarwala, et al.
American Journal of Cardiovascular Disease|November 23, 2020
Cardiovascular risk and complications associated with COVID-19Chayakrit Krittanawong, Anirudh Kumar, Joshua Hahn, et al.
Pageof 100

Showing results (531-540 of 999) with videos related to

Sort By:
Pageof 100
American Journal of Epidemiology|July 3, 2013
The association of plasma lactate with incident cardiovascular outcomes: the ARIC StudyKunihiro Matsushita, Emma K Williams, Morgana L Mongraw-Chaffin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2016
Defective Association of the Platelet Glycoprotein Ib-IX Complex with the Glycosphingolipid-Enriched Membrane Domain Inhibits Murine Thrombus and Atheroma FormationHao Zhou, Yali Ran, Qi Da, et al.
Plos One|February 28, 2019
Central and peripheral pulse wave velocity and subclinical myocardial stress and damage in older adultsShuiqing Liu, Esther D Kim, Aozhou Wu, et al.
The American Journal of Cardiology|September 1, 2021
Association of Longitudinal Changes in Cardiac Biomarkers With Atrial and Ventricular Arrhythmias (from the Atherosclerosis Risk in Communities [ARIC] Study)Parveen K Garg, Faye L Norby, Wendy Wang, et al.
Journal of the American College of Cardiology|September 1, 2025
Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients: A Pooled AnalysisStephen J Nicholls, Adam J Nelson, Kausik K Ray, et al.
The American Journal of Cardiology|December 14, 2016
Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients with Hypercholesterolemia or Low High-Density Lipoprotein CholesterolChristie M Ballantyne, Sukrut Shah, Uma Kher, et al.
American Journal of Preventive Cardiology|March 10, 2025
Inflammatory markers and calcification of coronary arteries, aorta and cardiac valves: Findings from the atherosclerosis risk in communities studyVennela Avula, Yejin Mok, Kentaro Ejiri, et al.
Stroke|May 11, 2013
Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities studyRazvan T Dadu, Myriam Fornage, Salim S Virani, et al.
Atherosclerosis|January 28, 2019
Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities studyAnum Saeed, Wensheng Sun, Anandita Agarwala, et al.
American Journal of Cardiovascular Disease|November 23, 2020
Cardiovascular risk and complications associated with COVID-19Chayakrit Krittanawong, Anirudh Kumar, Joshua Hahn, et al.
Pageof 100